Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07024719 · ClinicalTrials.gov registry record · NA
4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800
A NA study of Retinal Diseases and Corneal Diseases, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT07024719: Recruiting NA study of Retinal Diseases and Corneal Diseases, sponsored by Duke University.
NCT07024719 is a NA study of Retinal Diseases and Corneal Diseases that is actively recruiting participants, run by Duke University. The registered enrollment target is 5 participants, below the 396-participant average among 8 other Retinal Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07024719, a NA study of Retinal Diseases and Corneal Diseases, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team will conduct the first in-human pilot studies using 4D MIOCT for imaging in the operating room. Building on the earlier integration and wet-lab validations, the researchers will assess the system's ease of use, safety, and visualization of intended structures during various anterior and posterior segment ophthalmic procedures.
Primary Outcome
Determining subjective operator comfort and satisfaction using Likert Scales (Likert scores 1-5)
Conditions Studied
Interventions
- DEVICE 4D MIOCT integrated into a Zeiss Artevo 800
Study Locations (1)
North Carolina
- Duke University Eye Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-07-24 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT07024719 shows while recruiting
NCT07024719 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 396-participant average among 8 other Retinal Diseases trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Retinal Diseases appearing as the primary indexed condition, and to 1 intervention - of which 4D MIOCT integrated into a Zeiss Artevo 800 is the first listed.
NCT07024719 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07024719 about?
NCT07024719 is a clinical study titled "4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800". The study team will conduct the first in-human pilot studies using 4D MIOCT for imaging in the operating room. Building on the earlier integration and wet-lab validations, the researchers will assess the system's ease of use, safety, and visualization of intended structures during various anterior a...
What is the current status of trial NCT07024719?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-07-24. Estimated completion is 2026-10.
What conditions does trial NCT07024719 study?
This clinical trial studies the following conditions: Retinal Diseases, Corneal Diseases, Ocular Diseases.
What interventions are being tested in trial NCT07024719?
The interventions under investigation include: 4D MIOCT integrated into a Zeiss Artevo 800 (DEVICE).
Who is sponsoring clinical trial NCT07024719?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07024719 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07024719's enrollment target sits among peer trials
5 9th of 8 the lowest of 8 other Retinal Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Retinal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DISCOVER Study: Microscope-integrated Intraoperative OCT Study
RECRUITING
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations
ACTIVE NOT RECRUITING · Phase 1
-
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
ACTIVE NOT RECRUITING
-
Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD
COMPLETED · Phase 3
-
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI